Celltex responds in press release: FDA problems result of their Texas lab being run by Koreans, not Texans
Celltex has issued a press release (PR), entitled “Company Pioneering Regenerative Medicine Services Invited FDA to Inspect Lab” on their FDA audit in response to the reaction in the media and stem cell community about it. I view this PR as a step in the right direction–more openness! There is a lot of info in […]